• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - clinical
Tag:

clinical

Health

OmniActive’s Capsimax may work as a GLP-1 ‘booster’

by Chief Editor April 24, 2026
written by Chief Editor

The Rise of Natural GLP-1 Support: A New Era in Weight Wellness

The landscape of weight management is shifting. While pharmaceutical interventions have dominated recent headlines, a growing trend is emerging toward “natural GLP-1 boosters”—botanical ingredients that support the body’s own metabolic pathways without the need for synthetic stimulants.

View this post on Instagram about Capsimax, Weight
From Instagram — related to Capsimax, Weight

Recent clinical research published in the Academic Journal of Sports Science & Medicine highlights this shift, focusing on the role of capsaicinoids. Specifically, a branded Capsicum annuum extract known as Capsimax has demonstrated the ability to elevate natural GLP-1 levels by approximately 13% after just seven days of supplementation.

Pro Tip: When looking for metabolism boosters, prioritize “non-stimulant” profiles. These allow you to support energy expenditure without the jitters or crashes associated with high-caffeine formulations.

Beyond Weight Loss: The Convergence of Performance and Metabolism

We are seeing a convergence where “weight loss” supplements are evolving into “performance and wellness” tools. It is no longer just about shedding pounds; it is about optimizing how the body utilizes energy during and after a workout.

Beyond Weight Loss: The Convergence of Performance and Metabolism
Capsimax Weight Beyond Weight Loss

In a randomized, double-blind, placebo-controlled study involving resistance-trained men, a low dose of 100 mg of Capsimax (standardized to 2% capsaicinoids) didn’t just impact metabolic markers—it improved actual physical output. Participants saw significant gains in:

  • Peak Force and Velocity: Higher power output during resistance training.
  • Muscular Endurance: Improved performance in standard push-ups and squat tests.
  • Energy Expenditure: A significant increase in resting energy expenditure (REE), exceeding 120 kcal/day.

This suggests a future where athletes leverage botanical extracts to simultaneously manage body composition and enhance their strength and agility via evidence-based supplementation.

Did you know? Capsaicinoids are the bioactive compounds found in chili peppers. While raw peppers can be harsh on the stomach, standardized extracts like Capsimax are designed to be well-tolerated for everyday use without the intense sensory burn.

Fighting the “Invisible” Enemy: Oxidative Stress and Recovery

As high-intensity interval training (HIIT) and heavy resistance training remain popular, the industry is focusing more on mitigating the “micro trauma” caused by exercise. Physical activity creates reactive oxygen species—by-products of mitochondrial respiration that lead to oxidative stress and inflammation.

The trend is moving toward plant-derived compounds—such as polyphenols, terpenoids, and alkaloids—that offer antioxidant and vasodilatory effects. By reducing inflammation, these supplements can assist athletes recover faster and improve energy utilization in subsequent workouts.

Integrating these compounds with traditional macronutrient-based recovery (like protein and carbs) represents a holistic approach to athletic longevity. [Link to related article on muscle recovery strategies].

The Shift Toward “Consumer-Friendly” Thermogenics

Historically, capsaicin-based products were limited by their “harsh sensory effects.” However, the next generation of supplements is prioritizing the consumer experience. The goal is to deliver the thermogenic and lipolytic (fat breakdown) benefits of pepper extracts in a scalable, tasteless, and stomach-friendly format.

The Shift Toward "Consumer-Friendly" Thermogenics
Capsimax Weight Muscular Endurance

This evolution makes it possible to incorporate metabolic support into a wider variety of products, from daily wellness capsules to sports nutrition powders, without compromising the taste or comfort of the user.

Frequently Asked Questions

What is GLP-1 and why does it matter?
GLP-1 is a hormone that plays a key role in appetite management and metabolic health. Supporting its natural activity can help with weight wellness and glucose metabolism.

Frequently Asked Questions
Capsimax Weight Muscular Endurance

Can a supplement actually increase resting energy expenditure?
Yes. Clinical data shows that 100 mg of Capsimax can increase resting energy expenditure by more than 120 kcal per day.

Is Capsimax a stimulant?
No, it is a non-stimulant, low-dose botanical extract, making it a versatile option for those who want to avoid caffeine or other stimulants.

Does it help with athletic performance?
Research indicates improvements in peak force, rate of force development, and muscular endurance in resistance-trained individuals.

Join the Conversation

Are you incorporating botanical extracts into your fitness routine? Do you prefer non-stimulant options for weight management? Let us know in the comments below or subscribe to our newsletter for the latest in sports science!

Subscribe for Updates

April 24, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Major changes to type 2 diabetes treatment could save thousands of lives | National Institute for Health and Clinical Excellence (NICE)

by Chief Editor February 18, 2026
written by Chief Editor

Revolutionizing Diabetes Care: New Guidelines Promise Longer, Healthier Lives

Millions of people living with type 2 diabetes in the UK are set to benefit from significant changes to treatment guidelines, announced today by the National Institute for Health and Care Excellence (NICE). The new recommendations prioritize individual needs and promise to prevent thousands of heart attacks, strokes, and cases of kidney failure.

A Shift Towards Earlier Intervention with ‘Flozins’

For years, metformin has been the first line of defense in newly diagnosed type 2 diabetes. Now, NICE guidance suggests most patients should immediately start a combination of metformin and an SGLT-2 inhibitor – often called ‘flozins’ – tailored to their specific health profile. This proactive approach aims to protect both the heart and kidneys, addressing a leading cause of death for those with the condition.

Significant Cost Savings for the NHS

The changes aren’t just about improved patient outcomes; they also represent substantial savings for the National Health Service. The increasing availability of generic dapagliflozin is projected to save the NHS £560 million over the next two years (2025/26 and 2026/27). These funds can then be reinvested into other crucial areas of diabetes care, such as education programs and community support services.

Addressing Health Inequalities in Diabetes Treatment

A concerning trend identified by NICE reveals that SGLT-2 inhibitors are not being prescribed equitably. Analysis of anonymized patient records shows under-prescription among women, older individuals, and Black patients. The new guidance emphasizes monitoring prescription rates and actively working to close these gaps, ensuring fair access to life-saving treatments.

Did you know? Heart disease is the leading cause of death among people with type 2 diabetes, making kidney and heart protection a critical focus of new treatment strategies.

Personalized Treatment Plans: A Move Away From ‘One-Size-Fits-All’

Recognizing that every patient’s journey with type 2 diabetes is unique, the new guidelines champion a personalized approach. Healthcare professionals are encouraged to collaborate with patients, considering their individual health conditions, existing medications, and personal preferences when determining the best course of treatment. Regular check-ups will ensure treatments remain effective and well-tolerated.

Expanded Access to GLP-1 Receptor Agonists and Tirzepatide

Beyond SGLT-2 inhibitors, the guidance expands access to GLP-1 receptor agonists (like semaglutide, dulaglutide, and liraglutide) and tirzepatide for specific patient groups. These medications will now be recommended for individuals diagnosed before age 40, those living with obesity, and those with cardiovascular disease caused by blocked arteries. Approximately 810,000 more people could benefit from these expanded treatment options.

Pro Tip: Discuss your individual risk factors and treatment options with your healthcare provider to determine the most appropriate plan for managing your type 2 diabetes.

The Importance of Lifestyle Changes

While medication plays a vital role, the guidelines emphasize that a healthy lifestyle remains paramount. Doctors and nurses should discuss diet, physical activity, and other positive changes alongside any prescribed medications. The NHS Type 2 Diabetes Path to Remission Programme offers support for individuals seeking to achieve remission through lifestyle modifications.

Frequently Asked Questions

  • What are SGLT-2 inhibitors? These medications help the kidneys remove excess sugar from the body and have been shown to protect the heart, and kidneys.
  • Will I automatically be switched to a new medication? Your healthcare provider will discuss the new guidelines with you and determine the best treatment plan based on your individual needs.
  • What if I experience side effects from new medications? Healthcare professionals will introduce new medicines one at a time and monitor for any adverse effects. A slow-release form of metformin is also recommended to minimize stomach upset.
  • How will these changes affect the NHS budget? The apply of generic dapagliflozin is expected to save the NHS £560 million, allowing for reinvestment in other areas of care.

It’s a landmark moment for diabetes care, as Eric Power, interim director of the centre for guidelines at NICE, stated: “Our independent committee conducted a rigorous review of the evidence and concluded that by offering certain medicines earlier, You can prevent thousands of heart attacks, strokes and cases of kidney failure — keeping people healthier for longer while reducing pressure on NHS services.”

What are your thoughts on these new guidelines? Share your experiences and questions in the comments below!

Explore more articles on diabetes management and NHS healthcare updates.

February 18, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Colombia: Delays in Medical Food for Children with Cow’s Milk Allergy Risk Lives

by Chief Editor February 6, 2026
written by Chief Editor

Colombia’s Infant Health Crisis: Delays in Specialized Nutrition Put Babies at Risk

A growing number of families in Colombia are facing a harrowing situation: delays in accessing vital, specialized nutrition for their infants with severe food allergies, particularly to cow’s milk protein (CMPA). More than 1,120 complaints have been filed with the National Health Superintendency, highlighting a systemic issue that threatens the health and well-being of vulnerable children.

The Severity of CMPA and the Need for Timely Intervention

Cow’s Milk Protein Allergy (CMPA) is the most common food allergy in infancy. It’s not simply a digestive discomfort; it’s a potentially life-threatening immune response. Symptoms can range from digestive and respiratory issues to severe, potentially fatal anaphylactic reactions. For these infants, standard formulas are not an option. They require specialized medical foods (APME) – extensively hydrolyzed formulas or amino acid-based formulas – to thrive.

Dr. Juan Pablo Riveros, a member of the Board of Directors of the Colombian College of Pediatric Gastroenterology, Hepatology and Nutrition (Colgahnp), emphasizes the critical timeframe. Delays exceeding 20-30 days in receiving these specialized formulas can lead to growth retardation, low weight, cognitive development issues, and, tragically, anaphylaxis.

Real Stories of Struggle: Families Caught in the System

Ana María Hernández, a mother in Colombia, shared her desperate experience. Her 20-month-old son has been without his specialized nutrition for over three months, despite legal efforts like protective measures and appeals. The consequences have been severe: respiratory problems, colic, insomnia and stalled growth. “My son has been without specialized medical nutrition for more than three months. I have had to resort to legal remedies and appeals, but still the food is not delivered,” she stated.

Other parents, like Saray Pedrozo, whose three-year-old daughter has a tracheostomy and gastrostomy, report incomplete deliveries and recurrent hospitalizations due to malnutrition. Yaneth Sierra’s son, with Tarp syndrome and swallowing difficulties, has gone eight months without the necessary nutrition, resulting in moderate malnutrition.

What’s Causing the Delays?

According to the National Health Superintendency, the primary obstacles include delays in authorization (34.2%), incomplete or delayed deliveries (25.5%), denials of authorization (4.5%), and outright refusals to deliver (35.9%). These issues point to systemic problems within the Colombian healthcare system and the Entidades Promotoras de Salud (EPS) – health promoting entities.

Pro Tip: If you are facing delays in receiving approved medical nutrition for your child, immediately file a complaint with the National Health Superintendency and consider seeking legal counsel to explore options like a tutela (a constitutional protection action).

The Economic Impact of Untreated Allergies

The consequences of these delays extend beyond individual suffering. Untreated food allergies place a significant burden on the healthcare system, increasing the need for medication, specialist consultations, and hospitalizations. Globally, the economic impact is substantial; in the United States, the annual cost of food allergies is estimated at $24.8 billion, including medical expenses and economic losses for families.

Navigating the System: Resources for Families

Families facing these challenges are not alone. The legal route, particularly the tutela, is a crucial tool for protecting access to medical nutrition. Online platforms like Recepción de Tutela En Línea streamline the process of filing these requests. Health entities and the Public Defender’s Office can also provide guidance and support.

Did you recognize? Specialized medical foods (APME) are not optional or replaceable with standard formulas. They are essential for the health and survival of infants with CMPA and other severe food allergies.

FAQ

Q: What is CMPA?
A: Cow’s Milk Protein Allergy is a severe immune reaction to the proteins in cow’s milk, requiring specialized nutrition for infants.

Q: What are APME?
A: Alimentos con propósitos médicos especiales (Foods for Special Medical Purposes) are specialized formulas, like extensively hydrolyzed or amino acid-based formulas, designed for infants with CMPA and other medical conditions.

Q: What should I do if my child’s APME delivery is delayed?
A: File a complaint with the National Health Superintendency, seek legal counsel, and explore filing a tutela.

Q: Is CMPA life-threatening?
A: Yes, if left untreated, CMPA can lead to severe complications, including anaphylaxis, which can be fatal.

This situation demands urgent attention and systemic reform to ensure that all Colombian infants have timely access to the nutrition they need to survive and thrive. Share your experiences and advocate for change to protect the health of our most vulnerable population.

February 6, 2026 0 comments
0 FacebookTwitterPinterestEmail
Business

Stanford Center for Biomedical Ethics expands initiatives for ethics in genetics research

by Chief Editor January 24, 2025
written by Chief Editor

The Rise of Bioethics in the AI Era

The intersection of artificial intelligence (AI) and bioethics is becoming increasingly crucial as new technologies revolutionize healthcare and medical research. With the Stanford Center for Biomedical Ethics (SCBE) at the forefront, significant advancements and collaborations are shaping the future of ethical considerations in medicine.

Interdisciplinary Collaborations Driving Innovation

Stanford’s SCBE is leveraging its $9.4 million grant to spearhead initiatives in collaboration with institutions like Columbia University, the Hastings Center, and Case Western Reserve University. These partnerships foster multidisciplinary discourse, essential for tackling today’s ethical challenges in genetics, AI, and healthcare.

With a history of growth since its founding in 1989, SCBE now stands as a leader in coordinating ethical, legal, and social implications (ELSI) research, demonstrating the importance of interdisciplinary efforts in modern bioethics.

Addressing Inequities in AI Medical Data

A pressing concern in AI is the lack of diversity within medical datasets, particularly for underrepresented groups. This gap can lead to inaccurate or even harmful outcomes, echoing the biases endemic in existing systems. As Sandra Lee ’88 emphasizes, a proactive approach is needed to create inclusive datasets that reflect global populations.

Real-life examples, such as AI algorithms that perform poorly for certain racial groups due to biased training data, underscore the urgency of addressing these inequities. Efforts to diversify data are not only ethical imperatives but essential for creating more equitable healthcare solutions.

Enhancing Healthcare Through ELSI Innovations

Stanford’s ELSI programs, including the SCBE and CERA, provide platforms for discussions around the social implications of genetics and AI technologies. By hosting forums and seminars, these programs create opportunities for international dialogues and collaborations.

One long-term goal is expanding these conversations globally. Mildred Cho from SCBE highlights the importance of ensuring that research benefits reach the communities contributing samples, from financial support to improved healthcare access.

AI Ethics: Beyond Current Challenges

As AI continues to evolve, so does the need for ethical input in its development. Holly Tabo advocates for ethics to be deeply integrated into research, policy-making, and clinical applications. The aim is to anticipate future challenges and ensure technological growth aligns with human values and societal needs.

Initiatives such as the CERA’s TraineeHub exemplify efforts to build communities focused on these critical areas, facilitating the exchange of ideas and resources among global ELSI scholars.

FAQ Section

What role does the SCBE play in bioethics?

SCBE is a leading center for ELSI research, addressing ethical issues in medicine and genetics through interdisciplinary collaboration and outreach.

Why is diversity in AI datasets important?

Diverse datasets ensure AI technologies perform equitably across different demographics, reducing biases and potential harm.

How can individuals contribute to ethical AI development?

Individuals can engage with forums, contribute to discussions, and ensure diverse representation in research and development processes.

Call to Action

We encourage readers to share their thoughts in the comments below and explore more on the intersection of AI and bioethics. Consider subscribing to our newsletter for the latest insights and developments in this rapidly evolving field.

January 24, 2025 0 comments
0 FacebookTwitterPinterestEmail

Recent Posts

  • Snooker Star Blasts Pathetic Tournament Cancellation

    April 26, 2026
  • Jimmy Jam gives rare insights into Michael Jackson and Prince rivalry

    April 26, 2026
  • Why Is No One Taking Baby Aspirin for Heart Disease Prevention Anymore?

    April 26, 2026
  • I used the iPhone Air for six months — here are 5 things I learned

    April 26, 2026
  • Stranded Baltic Sea Whale Rescue: New Plan to Save Timmy

    April 26, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World